How I diagnose Erdheim-Chester disease
American Journal of Clinical Pathology · 04.08.2026 · 166 (2)
DOI: 10.1093/ajcp/aqag094 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 21.08.2026. Verfasst von Aishwarya Ravindran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Erdheim-Chester Disease. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Objectives
Erdheim-Chester disease (ECD) is one of 3 major types of histiocytic neoplasms, along with Rosai-Dorfman disease and Langerhans cell histiocytosis. It was first recognized as a neoplasm in the 2016 World Health Organization Classification of Haematolymphoid Tumours. About 80% to 90% of cases harbor MAPK pathway mutations.
Methods
We discuss the diagnosis of ECD using 3 illustrative cases, consider interpretative challenges, and present a diagnostic algorithm.
Results
Erdheim-Chester disease is a systemic disease that shows a characteristic pattern of organ involvement including bone, perinephric soft tissue, skin, heart, and central nervous system. Histologically, ECD shows a spectrum of xanthogranulomatous, lymphohistocytic, or fibrohistiocytic infiltrates. By immunohistochemistry, the neoplastic histiocytes have a macrophage phenotype with expression of CD163, negative to focal S100, and negative CD1a and langerin. These features alone are not specific and thus insufficient for diagnosis. Immunohistochemistry for cyclin D1 and BRAF V600E, correlation with clinical and imaging findings, and mutational analysis for MAPK pathway mutations all play important roles in establishing an ECD diagnosis.
Conclusions
The diagnosis of ECD is often challenging due to its clinical and histologic overlap with reactive inflammatory processes. Correlation of histology features with clinical findings, immunohistochemistry, and genetic studies is essential for an accurate and timely diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
Zitieren
APA
Ravindran, A., Rech, K. L., & Histio-Care Network (2026). How I diagnose Erdheim-Chester disease. American Journal of Clinical Pathology, 166(2). https://doi.org/10.1093/ajcp/aqag094
Vancouver
Ravindran A, Rech KL, Histio-Care Network. How I diagnose Erdheim-Chester disease. American Journal of Clinical Pathology. 2026;166(2). doi:10.1093/ajcp/aqag094
BibTeX
@article{Ravindran2026,
author = {Ravindran, Aishwarya and Rech, Karen L and Histio-Care Network, Histio-Care Network},
title = {How I diagnose Erdheim-Chester disease},
journal = {American Journal of Clinical Pathology},
year = {2026},
volume = {166},
number = {2},
doi = {10.1093/ajcp/aqag094}
}
EUVIMED